We report 8 patients with the acquired immunodeficiency syndrome (AIDS) and intracerebral haemorrhage. There were 7 men and 1 woman (mean age 37.2 years) with a mean CD4 count of 81.2/mm3. Alcohol abuse was recorded in 7 patients, intravenous drug use in 4, homosexual activity in 2, thrombocytopaenia in 1 and severe hypertension in 1. There were 5 lobar and 3 deep haemorrhages. Potential aetiologies of intracerebral haemorrhage included cerebral toxoplasmosis (n = 2), thrombocytopenia (n = 2), hypertension (n = 1) and cerebral tuberculosis (n = 1). Data of these patients were compared with those of 30 AIDS inpatients without brain haemorrhage matched by age and sex and no statistically significant differences in risk factors for AIDS except for alcohol abuse (>80 g/day) (p = 0.045) were found. Causes of brain haemorrhage in AIDS patients are heterogeneous. The relationship between both conditions may be explained by the effect of several predisposing factors to stroke in association with AIDS-related complications. Intracerebral haemorrhage is a late and serious complication of AIDS (mortality 62.5%). The frequency of intracerebral haemorrhage in AIDS (1.0%) is higher than that expected in a general population of young adults.

Keywords:
Cerebral haemorrhage, AIDS
1.
Pinto AN: AIDS and cerebrovascular disease. Stroke 1996;27:538–543.
2.
Centers for Disease Control: Update on acquired immunodeficiency syndrome. MMWR 1982;31:507–514.
3.
Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl 1S):3S–15S.
4.
Anders KH, Guerry WF, Tomiyasu U, Verity MA, Vinters HV: The neuropathology of AIDS. UCLA experience and reviews. Am J Pathol 1986;124:537–558.
5.
Berger JR, Harris JO, Gregorius J, Norenberg M: Cerebrovascular disease in AIDS: A case-control study. AIDS 1990;4:239–244.
6.
Mizusawa H, Hirano A, Llena JF, Shintaku M: Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1988;76:451–457.
7.
Moriarty DM, Haller JO, Loh JP, Fikrig S: Cerebral infarction in pediatric acquired immunodeficiency syndrome. Pediatr Radiol 1994;24:611–612.
8.
Park YD, Belman BA, Kim TS, et al: Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 1990;28:303–311.
9.
Atalaia A, Ferro J, Antunes F: Stroke in an HIV-infected patient. J Neurol 1992;239:356–357.
10.
Engstrom JW, Lowenstein DH, Bredesen DE: Cerebral infarction and transient neurological deficits associated with acquired immunodeficiency syndrome. Am J Med 1989;86:528–532.
11.
Guiloff RJ, Fuller GN: Other neurological diseases in HIV-1 infection: Clinical aspects; in Rudge P (ed): Neurological Aspects of Human Retroviruses. Baillières Clin Neurol 1992;1:185.
12.
Philippet P, Blanche S, Sebag G, Rodesch G, Griscelli C, Tardieu M: Stroke and cerebral infarcts in children infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 1994;148:965–970.
13.
Casado-Naranjo I, Lopez Trigo J, Ferrandiz A, Cervelló A, Navarro V: Hemorrhagic abscess in a patient with the acquired immunodeficiency syndrome. Neuroradiology 1989;31:289.
14.
Chaudhari AB, Singh A, Jindal S, Poon TP: Haemorrhage in cerebral toxoplasmosis. A report on a patient with the acquired immunodeficiency syndrome. S Afr Med J 1989;76:272–274.
15.
DeBehnke DJ, Angelos MG: Intracranial hemorrhage and hemophilia: Case report and management guidelines. J Emerg Med 1990;8:423–427.
16.
Debroucker T, Benhamida C, Bedos JP, Michon C, Matheron S, Vachon F: Formes hémorragiques de toxoplasmose cérébrale au cours de l’infection par le virus de l’immunodéficience humaine. Quatre observations. Ann Méd Interne (Paris) 1991;142:305–307.
17.
de Tezanos Pinto M, Fernandez J, Perez Bianco PR: Update of 156 episodes of central nervous system bleeding in hemophiliacs. Haemostasis 1992;22:259–267.
18.
Garavelli PL: Cerebral hemorrhage during AIDS. Acta Neurol (Napoli) 1993;15:151.
19.
Hernández Hernández JA, González-Moreno Portugal M, Casan Cava JM, Aloy Duch A, Llibre Codina JM, Capdevilla Morell JA: Endocarditis por Candida albicans con embolismo arterial periferico y aneurisma micotico cerebral en adicto a drogas por via parenteral. Rev Clin Esp 1993;192:223–225.
20.
Levy RM, Rosenbloom S, Perrett LV: Neuroradiologic findings in AIDS: A review of 200 cases. AJNR 1986;147:977–983.
21.
McArthur JC: Neurological manifestations of AIDS. Medicine 1987;66:407–437.
22.
Ragni MV, Bontempo FA, Myers DJ, Kiss JE, Oral A: Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs. Blood 1990;75:1267–1272.
23.
Trenkwalder P, Trenkwalder C, Feiden W, Vogl TJ, Einhaupl KM, Lydtin H: Toxoplasmosis with early intracerebral hemorrhage in a patient with the acquired immunodeficiency syndrome. Neurology 1992;42:436–438.
24.
Wijdicks EFM, Borleffs JCC, Hoepelman AIM, Jansen GH: Fatal disseminated hemorrhagic toxoplasmic encephalitis as the initial manifestation of AIDS. Ann Neurol 1991;29:683–686.
25.
Moskowitz LB, Hensley GT, Chan JC, Gregorios J, Conley FK: The neuropathology of acquired immune deficiency syndrome. Arch Pathol Lab Med 1984;108:867–872.
26.
Snider WD, Simpson DM, Nielsen S, et al: Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 1983;14:403–418.
27.
Casado Naranjo I, Toledo Santos JA, Antolin Rodríguez MA: Ischemic stroke as the sole manifestation of human immunodeficiency virus infection. Stroke 1992;23:117–118.
28.
Gwam J, Korbo L, Andersen J: AIDS med apoplektiform debut. Ugeskr Laeger 1994;156:1313–1314.
29.
Scaravilli F, Daniel SE, Harcourt-Webster N, Guiloff RJ: Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome: A possible role for human immunodeficiency virus. Arch Pathol Lab Med 1989;113:192–195.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.